An update from Shanghai Pharmaceuticals Holding Co ( (HK:2607) ) is now available.
Shanghai Pharmaceuticals Holding Co., Ltd. has established a Nomination Committee under its Board of Directors to enhance its corporate governance structure. The committee is tasked with analyzing and recommending candidates for directorship and senior management roles, ensuring a diverse and independent board composition that aligns with regulatory requirements.
More about Shanghai Pharmaceuticals Holding Co
Shanghai Pharmaceuticals Holding Co., Ltd. operates in the pharmaceutical industry, focusing on the development, manufacturing, and distribution of pharmaceutical products. The company is a key player in the Chinese market, adhering to the regulatory standards of the People’s Republic of China and the Hong Kong Stock Exchange.
YTD Price Performance: -8.59%
Average Trading Volume: 33,967
Technical Sentiment Signal: Sell
Current Market Cap: $7.67B
Find detailed analytics on 2607 stock on TipRanks’ Stock Analysis page.